Peru vs South Sudan: HIV/AIDS deaths averted by antiretroviral therapy
Peru
6,549 deaths
in 2024
South Sudan
6,931 deaths
in 2024
Peru rank
30th
South Sudan rank
29th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Peru
- South Sudan
How they compare
South Sudan currently reports 6,931 deaths against 6,549 deaths in Peru, a difference of 382 deaths.
That makes South Sudan's figure about 1.1 times Peru's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was South Sudan ahead.
Peru ranks 30th and South Sudan ranks 29th of 157 countries.
Peru has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Peru | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 908.88 deaths | 53.17 deaths | 855.71 deaths | Peru |
| 2010s | 4,028 deaths | 2,048 deaths | 1,981 deaths | Peru |
| 2020s | 6,039 deaths | 5,394 deaths | 644.64 deaths | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Peru or South Sudan?
- South Sudan, at 6,931 deaths against 6,549 deaths in Peru as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Peru and South Sudan?
- 382 deaths, with South Sudan ahead.
- How many years of comparable data are there for Peru and South Sudan?
- 35 years are reported by both, from 1990 to 2024.
- How do Peru and South Sudan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Peru ranks 30th and South Sudan ranks 29th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.